125 related articles for article (PubMed ID: 18157949)
1. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation.
Shano S; Hatanaka K; Ninose S; Moriyama R; Tsujiuchi T; Fukushima N
Biochim Biophys Acta; 2008 May; 1783(5):748-59. PubMed ID: 18157949
[TBL] [Abstract][Full Text] [Related]
2. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y
Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043
[TBL] [Abstract][Full Text] [Related]
3. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
4. P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.
Lee M; Choi S; Halldén G; Yo SJ; Schichnes D; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G641-54. PubMed ID: 19679818
[TBL] [Abstract][Full Text] [Related]
5. Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors.
Hains MD; Wing MR; Maddileti S; Siderovski DP; Harden TK
Mol Pharmacol; 2006 Jun; 69(6):2068-75. PubMed ID: 16554409
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Biochem Biophys Res Commun; 2020 Nov; 532(3):427-432. PubMed ID: 32883524
[TBL] [Abstract][Full Text] [Related]
7. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.
Fang X; Yu S; LaPushin R; Lu Y; Furui T; Penn LZ; Stokoe D; Erickson JR; Bast RC; Mills GB
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):135-43. PubMed ID: 11062066
[TBL] [Abstract][Full Text] [Related]
9. Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2.
Seasholtz TM; Radeff-Huang J; Sagi SA; Matteo R; Weems JM; Cohen AS; Feramisco JR; Brown JH
J Neurochem; 2004 Oct; 91(2):501-12. PubMed ID: 15447683
[TBL] [Abstract][Full Text] [Related]
10. Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.
Ambesi A; McKeown-Longo PJ
Mol Cancer Res; 2009 Feb; 7(2):255-65. PubMed ID: 19208746
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
[TBL] [Abstract][Full Text] [Related]
12. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho.
Gohla A; Harhammer R; Schultz G
J Biol Chem; 1998 Feb; 273(8):4653-9. PubMed ID: 9468525
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
14. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases.
Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J
Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524
[TBL] [Abstract][Full Text] [Related]
16. GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.
Lee CW; Rivera R; Gardell S; Dubin AE; Chun J
J Biol Chem; 2006 Aug; 281(33):23589-97. PubMed ID: 16774927
[TBL] [Abstract][Full Text] [Related]
17. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells.
Li Y; Gonzalez MI; Meinkoth JL; Field J; Kazanietz MG; Tennekoon GI
J Biol Chem; 2003 Mar; 278(11):9585-91. PubMed ID: 12524451
[TBL] [Abstract][Full Text] [Related]
19. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells.
Hayashi M; Okabe K; Kato K; Okumura M; Fukui R; Fukushima N; Tsujiuchi T
Cancer Lett; 2012 Mar; 316(1):91-6. PubMed ID: 22079467
[TBL] [Abstract][Full Text] [Related]
20. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
